Latest / DDReg Knowledge Capsule / Navigating the UAE's MOHAP to EDE Transition

Transcript

Navigating the UAE's MOHAP to EDE Transition · DDReg Knowledge Capsule

• 0:00
  Speaker 1: Welcome to DDRA Acknowledge capsule. You know, when you walk
• 0:03
  Speaker 1: into a modern hospital or even just a local clinic,
• 0:07
  Speaker 1: you just sort of expect the tech to be there.
• 0:09
  Speaker 2: Oh, absolutely, you just assume it works.
• 0:11
  Speaker 1: Yeah, exactly. You see these pristine MRI machines or the
• 0:14
  Speaker 1: sterile surgical implants, and you think they just effortlessly appeared
• 0:17
  Speaker 1: where they needed to be. But if you actually zoom
• 0:20
  Speaker 1: out and look at how these high stakes devices navigate
• 0:23
  Speaker 1: the hidden gatekeepers of global healthcare, well that expectation of
• 0:28
  Speaker 1: a clean, simple process completely vanishes.
• 0:32
  Speaker 2: It really does, because I mean the reality behind the
• 0:34
  Speaker 2: scenes is it's anything but simple. Behind every single syringe
• 0:39
  Speaker 2: or diagnostic software, there is this massive, invisible maze of
• 0:43
  Speaker 2: regulatory architecture and it's designed to be rigorous, like sometimes
• 0:46
  Speaker 2: brutally rigorous, because human lives are literally on the line, Which.
• 0:51
  Speaker 1: Brings us to today's topic. Today, we are taking a
• 0:54
  Speaker 1: deep dive into one of the most rapidly shifting regulatory
• 0:57
  Speaker 1: landscapes in the world right now, which is the airb Emirates.
• 1:01
  Speaker 2: Oh, the UAE is fascinating right now.
• 1:03
  Speaker 1: It is, And if you follow global markets you already
• 1:05
  Speaker 1: know the UAE is this incredibly fast growing healthcare hub
• 1:09
  Speaker 1: in the Middle East. But what you might not know
• 1:13
  Speaker 1: is that they are undergoing a massive regulatory overhaul for
• 1:16
  Speaker 1: medical devices. So we've got our hands on a detailed briefing.
• 1:19
  Speaker 1: It's titled the UAE Medical Device Regulations mohapp to ed Transition.
• 1:24
  Speaker 2: Guide, right, the Transition Guide.
• 1:26
  Speaker 1: Yeah, and this is from d drag Pharma, dated August fourteenth,
• 1:29
  Speaker 1: twenty twenty six.
• 1:30
  Speaker 2: And I have to say it is a phenomenal document
• 1:34
  Speaker 2: to unpack because what we're looking at here isn't just
• 1:37
  Speaker 2: you know, a slight administrative tweak or a new paperwork form.
• 1:40
  Speaker 1: It's way bigger than that.
• 1:42
  Speaker 2: It's a complete paradigm shift. The UAE is effectively rewriting
• 1:46
  Speaker 2: the fundamental rule book for anyone, and I mean anyone
• 1:49
  Speaker 2: trying to bring medical technology into their borders exactly.
• 1:52
  Speaker 1: So look, whether you are a regulatory professional dealing with
• 1:55
  Speaker 1: international submissions every single day, or maybe you're manufacturer trying
• 1:59
  Speaker 1: to expand your global footprint, or even if you're just
• 2:02
  Speaker 1: someone who is fascinated by global healthcare systems, our mission today.
• 2:05
  Speaker 2: Is simple, right, let's lay it out.
• 2:07
  Speaker 1: We are going to cut through all the bureaucratic jargon,
• 2:10
  Speaker 1: and we're going to extract the exact blueprint of what
• 2:13
  Speaker 1: this shift means, what it costs, and how you actually
• 2:16
  Speaker 1: survive the transition.
• 2:18
  Speaker 2: Surviving it is going to require a really deep understanding
• 2:21
  Speaker 2: of not just the rules on paper, but the actual
• 2:24
  Speaker 2: mechanics behind them.
• 2:25
  Speaker 1: Okay, let's unpack this big shift. For years, if you
• 2:29
  Speaker 1: wanted to get a medical device into the UAE, you
• 2:32
  Speaker 1: went through the Ministry of Health and Prevention, right MOHAP, Right, MOHAP.
• 2:36
  Speaker 1: That was the standard for a long time.
• 2:38
  Speaker 2: But then the government decided to completely restructure that authority.
• 2:41
  Speaker 2: This was triggered by federal dacree Law number thirty eight
• 2:44
  Speaker 2: of twenty twenty four, and they introduced this brand new entity,
• 2:48
  Speaker 2: the EDE.
• 2:49
  Speaker 1: Yeah, the Emirates Drug Establishment and that twenty twenty four decree.
• 2:53
  Speaker 1: I mean, it is the absolute lynchpin of everything we're
• 2:56
  Speaker 1: discussing today.
• 2:57
  Speaker 2: It changes everything.
• 2:58
  Speaker 1: It officially takes all that regulatory power previously housed within
• 3:01
  Speaker 1: MOHAP and transfers it entirely to the EDE. But and
• 3:05
  Speaker 1: this is crucial, they didn't just take the same people
• 3:07
  Speaker 1: and processes and you know, slap a new acronym on
• 3:10
  Speaker 1: the door, right to put this into perspective. Navigating the
• 3:13
  Speaker 1: old MOHAP system was sort of like driving down a
• 3:15
  Speaker 1: highway and having to stop at seven different tollbooths, each
• 3:18
  Speaker 1: with slightly different rules depang on which emmorate you were in.
• 3:21
  Speaker 2: That's a great way to put it. It was very fragmented.
• 3:23
  Speaker 1: Yeah, fragmented and frustrating. But what the EDE does is
• 3:27
  Speaker 1: it's like they bulldozed the toll booths and built a
• 3:30
  Speaker 1: single high speed digital easy pass lane for the entire country.
• 3:35
  Speaker 1: They standardized the grid into one unified federal authority covering
• 3:40
  Speaker 1: all seven emirates.
• 3:41
  Speaker 2: If we connect this to the bigger picture, this is
• 3:43
  Speaker 2: really about the UAE harmonizing its system with the absolute
• 3:47
  Speaker 2: highest international standards.
• 3:49
  Speaker 3: They want to be world class exactly.
• 3:51
  Speaker 2: By moving from that fragmented legacy system to this single specialized,
• 3:57
  Speaker 2: highly digital authority, they are drastically improving transparency and systemic efficiency.
• 4:02
  Speaker 1: So it's a digital first approach now totally.
• 4:05
  Speaker 2: They built this modern infrastructure from the ground up, and
• 4:08
  Speaker 2: that is exactly why companies have to completely rethink their
• 4:12
  Speaker 2: regulatory strategies moving forward. The EDES systems will govern everything,
• 4:17
  Speaker 2: every registration, every import license.
• 4:20
  Speaker 1: And the briefing specifically mentions that all of this is
• 4:22
  Speaker 1: processed through an ECTD system.
• 4:24
  Speaker 2: Yes, the ECTD.
• 4:25
  Speaker 1: So what does that actually look like for a manufacturer
• 4:28
  Speaker 1: on a practical level, I mean, what is ECTD.
• 4:31
  Speaker 2: So ECTD stands for Electronic Common Technical Document. For a manufacturer,
• 4:36
  Speaker 2: it basically means the era of mailing massive, disorganized binders
• 4:41
  Speaker 2: of paper to a government office is entirely over, thank goodness, right,
• 4:45
  Speaker 2: But it also means the ECTD is this highly structured,
• 4:48
  Speaker 2: globally recognized digital format. When you submit your dossier to
• 4:52
  Speaker 2: the EDE, it enters a centralized digital hub.
• 4:55
  Speaker 1: Okay, so it's all automated, it is.
• 4:58
  Speaker 2: And if your digital submission isn't formatted perfectly, or you know,
• 5:00
  Speaker 2: if a single file is out of place, the system
• 5:03
  Speaker 2: can essentially reject it before a human even really looks
• 5:05
  Speaker 2: at it.
• 5:06
  Speaker 3: Oh why just an automatic bounce exactly.
• 5:08
  Speaker 2: You can't rely on old workarounds or like knowing a
• 5:12
  Speaker 2: guy in a local office anymore. Your digital architecture has
• 5:15
  Speaker 2: to be absolutely flawless.
• 5:17
  Speaker 1: Okay. So if I'm a manufacturer, right and I'm looking
• 5:19
  Speaker 1: at this new unified digital tollbooth, what is the actual
• 5:23
  Speaker 1: cost of entry? Like, what are the hard numbers if
• 5:26
  Speaker 1: I want to get my device into hospitals in Dubai
• 5:28
  Speaker 1: and Abu Dhabi.
• 5:29
  Speaker 2: Well, the EDE has actually been very transparent about their metrics,
• 5:33
  Speaker 2: which is a huge benefit for businesses trying to map
• 5:36
  Speaker 2: out their financial runways.
• 5:37
  Speaker 1: Yeah, the briefing lays out the hard numbers pretty clearly.
• 5:40
  Speaker 1: So if you are applying for a marketing authorization, the
• 5:42
  Speaker 1: processing time is listed at forty.
• 5:44
  Speaker 3: Five working days, which is pretty fast.
• 5:46
  Speaker 1: Right, and the registration fee is five thousand UAE derms
• 5:50
  Speaker 1: plus a small application fee of one hundred germs. And
• 5:53
  Speaker 1: once you get it, that authorization is valid for five years.
• 5:56
  Speaker 2: And we should definitely pause on that timeline because forty
• 5:59
  Speaker 2: five working days relatively swift in global regulations. However, that
• 6:03
  Speaker 2: forty five day clock only reflects a smooth process if,
• 6:06
  Speaker 2: and literally only, if your submission dossier is impeccable from
• 6:09
  Speaker 2: day one, all.
• 6:10
  Speaker 1: Right, because you don't just wire five thousand dirhams and
• 6:13
  Speaker 1: get an automatic pass. You have to definitively prove your
• 6:16
  Speaker 1: device belongs there. And the required evidence in this briefing,
• 6:21
  Speaker 1: I mean, it's an intense.
• 6:22
  Speaker 3: Checklist, it really is.
• 6:23
  Speaker 2: They want everything.
• 6:24
  Speaker 1: Yeah, you need technical specifications of free sale certificate safety
• 6:27
  Speaker 1: and performance data, and it demands quality certifications, specifically highlighting
• 6:32
  Speaker 1: IO one three four eighty five for manufacturing sites.
• 6:36
  Speaker 2: Ah, yes, I sow one three four eight five.
• 6:39
  Speaker 1: So for a listener who maybe isn't deep in the
• 6:41
  Speaker 1: manufacturing weeds, what is the actual function of that? Why
• 6:45
  Speaker 1: does the EDE care about an ISO certificate?
• 6:48
  Speaker 2: It's a really great question because it's easy to look
• 6:50
  Speaker 2: at that as just another bureaucratic acronym. Right, but IO
• 6:53
  Speaker 2: one three four eight five is a globally recognized standard
• 6:57
  Speaker 2: for quality management systems, specifically for medical devices. Okay, think
• 7:01
  Speaker 2: about it from the UAE regulator's perspective. Imagine you are
• 7:04
  Speaker 2: manufacturing a highly complex surgical robot, but your facility is
• 7:08
  Speaker 2: outside Munich, Germany.
• 7:09
  Speaker 3: Right, thousands of miles away Exactly.
• 7:11
  Speaker 2: The UAE regulators cannot realistically fly out to Munich every
• 7:15
  Speaker 2: single week to inspect your assembly line. So the ISO
• 7:18
  Speaker 2: certificate is verified third party proof that your factory operates
• 7:22
  Speaker 2: with a quality management system the EDE can trust.
• 7:25
  Speaker 1: Oh I see, so it proves your process is safe
• 7:27
  Speaker 1: and consistent.
• 7:27
  Speaker 3: Exactly.
• 7:28
  Speaker 2: It's a proxy for trust.
• 7:29
  Speaker 1: Okay, that makes perfect sense. But there's another requirement here
• 7:32
  Speaker 1: that I actually want to push back.
• 7:33
  Speaker 3: On a little bit.
• 7:34
  Speaker 4: Okay, let's hear the EDE requires proof of international conformity,
• 7:40
  Speaker 4: so you have to show them a medical device ce
• 7:42
  Speaker 4: mark from Europe or FDA clearance from the US.
• 7:45
  Speaker 2: Yes, that's mandatory.
• 7:46
  Speaker 1: Well wait, if I'm a manufacturer and I already have
• 7:49
  Speaker 1: FDA clearance, I have just survived one of the most
• 7:52
  Speaker 1: grueling regulatory gauntlets on the planet, right about it? Doubt
• 7:56
  Speaker 1: so I've already proven it safe. Why on Earth do
• 7:59
  Speaker 1: I need to wait, in addition, forty five days and
• 8:01
  Speaker 1: build an entirely local UAE dot CAA. Why isn't this
• 8:05
  Speaker 1: just a weber stamp?
• 8:06
  Speaker 2: This raises an important question, and it really gets to
• 8:08
  Speaker 2: the very heart of how sovereign nations handle public health.
• 8:12
  Speaker 2: An FDA clearance or a ce mark is excellent proof
• 8:15
  Speaker 2: of concept.
• 8:16
  Speaker 1: Right says this works?
• 8:17
  Speaker 2: It tells the EDE, Okay, this device is fundamentally sound.
• 8:22
  Speaker 2: But a local regulator has a sovereign mandate to protect
• 8:25
  Speaker 2: their specific population. They have to verify that the device
• 8:29
  Speaker 2: aligns with the UAE's distinct risk classifications and critically, their
• 8:34
  Speaker 2: specific local market conditions.
• 8:36
  Speaker 1: Wait, what do you mean by local market conditions? We're
• 8:38
  Speaker 1: talking about like the physical environment.
• 8:40
  Speaker 2: Absolutely, think about the climate.
• 8:42
  Speaker 4: Right.
• 8:43
  Speaker 2: A medical device, say a portable diagnostic tool, might operate
• 8:47
  Speaker 2: flawlessly in the temperate weather of Seattle or London. Sure,
• 8:51
  Speaker 2: but how does that exact same physical device handle the
• 8:54
  Speaker 2: extreme desert climate of the UAE. Does the intense heat
• 8:59
  Speaker 2: or the humidity affect the battery life? Does it degrade
• 9:02
  Speaker 2: the plastics?
• 9:03
  Speaker 1: Oh? Wow, I didn't even think about the heat degrading
• 9:06
  Speaker 1: the materials?
• 9:06
  Speaker 3: Right?
• 9:06
  Speaker 2: And furthermore, the EDE has to look at local demographics.
• 9:10
  Speaker 2: Are the instructions inherently clear for the local population and
• 9:13
  Speaker 2: medical staff? So that extra forty five days isn't just friction,
• 9:17
  Speaker 2: it's the EDE doing rigorous due diligence to ensure a
• 9:20
  Speaker 2: product built in the US is genuinely safe in their
• 9:22
  Speaker 2: specific reality.
• 9:23
  Speaker 1: Wow. Okay, Yeah, the climate factor alone is a brilliant
• 9:26
  Speaker 1: way to look at it. You just can't assume global uniformity.
• 9:30
  Speaker 2: No, you really can't.
• 9:31
  Speaker 1: And that actually perfectly frames the next massive hurdle because
• 9:34
  Speaker 1: if you just read the fee structure, bay the Durhams,
• 9:37
  Speaker 1: show your ce mark, upload your files. It sounds deceptively easy,
• 9:42
  Speaker 1: but the briefing makes it clear that companies are just
• 9:45
  Speaker 1: tripping over the red tape.
• 9:46
  Speaker 2: Right now, Oh constantly. The transition to EDE has laid
• 9:51
  Speaker 2: bare a lot of pitfalls that are delaying market access
• 9:53
  Speaker 2: for months, sometimes leaving companies entirely stranded.
• 9:57
  Speaker 1: Yeah, the briefing lists of major traps. Number one is
• 10:00
  Speaker 1: inaccurate device risk classification. That's a big one, right, meaning
• 10:04
  Speaker 1: if the EDE considers your device a Class three high
• 10:07
  Speaker 1: risk implan, but you submit your dossier arguing it's a
• 10:10
  Speaker 1: Class to moderate risk device, your entire submission is basically
• 10:13
  Speaker 1: invalid the moment you hit send.
• 10:15
  Speaker 2: And you've just lost months of momentum exactly.
• 10:18
  Speaker 1: But the pitfall that really caught my eye, the one
• 10:20
  Speaker 1: that seems so tricky, is the labeling rule. The EDE
• 10:23
  Speaker 1: demands that artwork labeling and the instructions for us to
• 10:26
  Speaker 1: if us they must be strictly bilingual, right, English and Arabic,
• 10:30
  Speaker 1: formatted in both English and Arabic.
• 10:32
  Speaker 2: And we really really need to emphasize the word formatted
• 10:34
  Speaker 2: here because translating technical medical jargon into Arabic isn't something
• 10:40
  Speaker 2: you can just you know, run through Google translation.
• 10:42
  Speaker 1: Oh, defer not.
• 10:43
  Speaker 2: It requires highly specialized clinical translation to ensure absolute medical accuracy.
• 10:50
  Speaker 2: But beyond just the language. Arabic reads right to left right.
• 10:54
  Speaker 1: So if you're listening to this and you work in
• 10:56
  Speaker 1: product design, you're probably sweating right now.
• 10:59
  Speaker 3: It should be.
• 11:00
  Speaker 2: It completely alters the physical layout of the packaging, the artwork,
• 11:04
  Speaker 2: even the software interfaces.
• 11:05
  Speaker 1: Oh man, the software interfaces too.
• 11:07
  Speaker 2: Think about it. If you have a portable defibrillator, the
• 11:10
  Speaker 2: emergency user interface, the physical buttons, the warning labels on
• 11:14
  Speaker 2: the screen. If your design was built strictly for left
• 11:17
  Speaker 2: to right English, mirroring all of that to comply with
• 11:22
  Speaker 2: right to left Arabic formatting is a massive structural change.
• 11:25
  Speaker 1: That sounds like an engineering nightmare.
• 11:27
  Speaker 2: It is. If you aren't prepared, and if your label
• 11:30
  Speaker 2: layout doesn't fully comply with EDE standards, your product simply
• 11:34
  Speaker 2: does not enter the country.
• 11:36
  Speaker 1: Which brings us to the representation mandate. And the briefing
• 11:39
  Speaker 1: is crystal clear on this. Foreign manufacturers cannot just you
• 11:44
  Speaker 1: log onto the EDE website from their headquarters in Chicago
• 11:47
  Speaker 1: and hit submit. Nope, not allowed. They are legally required
• 11:50
  Speaker 1: to have an authorized local representative, distributor, or regulatory partner
• 11:55
  Speaker 1: physically based in the UAE.
• 11:57
  Speaker 2: This is a foundational pillar of the UAE use regulatory philosophy.
• 12:02
  Speaker 2: They absolutely demand a localized point of accountability.
• 12:06
  Speaker 1: Here's where it gets really interesting to me. Is this
• 12:08
  Speaker 1: local representative requirement just like a bureaucratic tax? You know
• 12:12
  Speaker 1: what I mean? Am I just paying a retainer fee
• 12:14
  Speaker 1: for a rented mailing address in Dubai so I can
• 12:16
  Speaker 1: check a box? Or is this a deeper operational partnership?
• 12:20
  Speaker 2: Emphatically, it is not just a mailbox, a true local partner,
• 12:24
  Speaker 2: and the briefing actually references organizations like dd REG as
• 12:28
  Speaker 2: an example of this. They are a deeply integrated operational asset.
• 12:31
  Speaker 1: Okay, so what are they actually doing well?
• 12:34
  Speaker 2: The UAE needs a legal entity inside their borders that
• 12:38
  Speaker 2: they can hold accountable if a device malfunctions and hurts
• 12:41
  Speaker 2: a patient. The government isn't going to try and sue
• 12:44
  Speaker 2: a ghost corporation operating out of Berlin. They go straight
• 12:47
  Speaker 2: to the authorized local representative.
• 12:49
  Speaker 1: Oh I see. So the stakes for the local partner
• 12:51
  Speaker 1: are huge too. What does that partnership look like day
• 12:54
  Speaker 1: to day? Before you even get the license, the local.
• 12:56
  Speaker 2: Partner is essentially in the trenches navigating all these neurals.
• 13:00
  Speaker 2: They undertake pre audits of your documentation, they validate your
• 13:04
  Speaker 2: good manufacturing practices.
• 13:06
  Speaker 1: Making sure you actually meet that ISO one three four
• 13:09
  Speaker 1: eight five interpretation exactly.
• 13:12
  Speaker 2: They compile the ECTD dots so it doesn't bounce back automatically.
• 13:16
  Speaker 2: They manage that highly complex bilingual Arabic artwork compliance we
• 13:20
  Speaker 2: just talked about. Basically, a specialized regulatory partner acts as
• 13:23
  Speaker 2: the crucial translation.
• 13:25
  Speaker 1: Bridge, and not just for language.
• 13:26
  Speaker 4: Right.
• 13:27
  Speaker 2: They translate a foreign manufacturer's capabilities into the ed's strict
• 13:31
  Speaker 2: legal requirements. Without that operational integration, you just don't get
• 13:34
  Speaker 2: access to the market.
• 13:36
  Speaker 1: Okay, So let's play this out. Let's say a manufacturer
• 13:38
  Speaker 1: listening to this does everything perfectly. Okay, They nail their
• 13:41
  Speaker 1: risk classification, Their bilingual right to left interfaces are slawless.
• 13:45
  Speaker 1: They hire a deeply integrated local partner who takes on
• 13:48
  Speaker 1: that accountability. They pay the five thousand durhams, the forty
• 13:52
  Speaker 1: five days pass, and the EDE grants the marketing authorization.
• 13:57
  Speaker 2: Great, they're in.
• 13:58
  Speaker 1: I pop the champagne right, the five year clock starts
• 14:01
  Speaker 1: and I can just pivot my entire team strictly to sales.
• 14:04
  Speaker 2: I hate to burst the bubble, but no, not even close. Now,
• 14:08
  Speaker 2: in the eyes of the regulator, gaining that authorization is
• 14:11
  Speaker 2: merely the starting line.
• 14:12
  Speaker 1: This is a huge theme in the briefing. The obligations
• 14:15
  Speaker 1: do not cease at authorization. You get a five year
• 14:17
  Speaker 1: validity window, but that window is entirely conditional on something
• 14:21
  Speaker 1: called continuous postmarket surveillance.
• 14:23
  Speaker 2: The EDE is sending a very clear message here medical
• 14:27
  Speaker 2: device organizations must be continually compliant. Getting the license isn't
• 14:31
  Speaker 2: a one and done transaction. It's an active, ongoing relationship
• 14:35
  Speaker 2: with the federal authority.
• 14:36
  Speaker 1: So what does this all mean. To use an analogy,
• 14:38
  Speaker 1: it's like getting the EDE license is just passing the
• 14:41
  Speaker 1: safety inspection to get your race car out onto the track.
• 14:44
  Speaker 1: But the real work, the actual challenge, is the continuous
• 14:47
  Speaker 1: driving because over those next five years, you have to
• 14:50
  Speaker 1: handle local complaints, document any variations to the device.
• 14:54
  Speaker 2: Yeah, even tiny variations, right.
• 14:56
  Speaker 1: Like if you update an internal component or tweak a
• 14:58
  Speaker 1: software algorithm. The EDE needs to know, and you have
• 15:02
  Speaker 1: to actively prepare for that five year license renewal.
• 15:05
  Speaker 2: What's fascinating here is how the EDE applies the concept
• 15:09
  Speaker 2: of pharmacovigilance or PV so rigorously to physical medical devices.
• 15:15
  Speaker 1: Yeah. Usually when we hear pharmacovigilance we think of pharmaceuticals
• 15:17
  Speaker 1: right exactly tracking chemical side effects of a drug in
• 15:20
  Speaker 1: the human body.
• 15:21
  Speaker 2: But the EDE demands a robust operational PV framework for
• 15:26
  Speaker 2: devices as well, And.
• 15:27
  Speaker 1: The briefing gets really specific about what this local safety
• 15:29
  Speaker 1: framework looks like. It mentions managing psurs, which are periodic
• 15:33
  Speaker 1: safety update reports. It mandates rapid reporting of adverse events,
• 15:37
  Speaker 1: and it requires the recruitment of a QPPV.
• 15:41
  Speaker 2: Yes, the QPPV.
• 15:42
  Speaker 1: What exactly is a QPPV and how do they function
• 15:45
  Speaker 1: in this environment?
• 15:46
  Speaker 2: So QPPV stands for Qualified person for Pharmacovigilance. This is
• 15:52
  Speaker 2: a designated, highly trained individual whose entire job is to
• 15:56
  Speaker 2: actively monitor the safety profile of your product while it
• 16:00
  Speaker 2: is out there in the real world, okay, And they
• 16:02
  Speaker 2: act as the direct line of communication with the regulatory authority.
• 16:06
  Speaker 1: So if my device, let's say, a vital signs monitor,
• 16:09
  Speaker 1: starts malfunctioning or throwing error codes in a small clinic
• 16:12
  Speaker 1: in Charja, the QPPV is the one gathering that data.
• 16:16
  Speaker 2: Exactly, they gather that adverse event data, they analyze it,
• 16:19
  Speaker 2: and they ensure it is rapidly reported to the EDE.
• 16:22
  Speaker 2: They are also the ones responsible for compiling those periodic
• 16:25
  Speaker 2: safety update.
• 16:25
  Speaker 1: Reports you mentioned psurs.
• 16:27
  Speaker 2: A PSUR is essentially a massive, regular audit of the
• 16:30
  Speaker 2: device's performance across the entire market.
• 16:33
  Speaker 1: Honestly, that sounds incredibly resource intensive for a manufacturer to
• 16:36
  Speaker 1: maintain for five straight years.
• 16:38
  Speaker 2: It is resource intensive, but think about the why behind it.
• 16:41
  Speaker 2: The goal is continuous compliance to ensure that safety standards never.
• 16:45
  Speaker 3: Drop over time because things break down exactly.
• 16:48
  Speaker 2: A device might pass a pristine laboratory inspection on day one,
• 16:52
  Speaker 2: but how does the physical hardware hold up after three
• 16:55
  Speaker 2: years of heavy daily use in a bustling Dubai emergency room.
• 16:59
  Speaker 2: The e d's Post market Vigilance framework protects the public
• 17:03
  Speaker 2: by identifying wear and tear issues, battery degradations, or systemic
• 17:08
  Speaker 2: software glitches incredibly.
• 17:09
  Speaker 1: Early, and it holds the manufacturers globally accountable.
• 17:12
  Speaker 2: Precisely, if a foreign manufacturer knows they are legally bound
• 17:16
  Speaker 2: to continuously submit these safety reports through their local QPPV,
• 17:21
  Speaker 2: they are highly incentivized to maintain absolute quality control long
• 17:25
  Speaker 2: long after the product has left their factory floor in
• 17:28
  Speaker 2: Europe or America.
• 17:29
  Speaker 1: It really paints a vivid picture of a living, breathing
• 17:32
  Speaker 1: regulatory system. It's not just a static piece of paper.
• 17:36
  Speaker 1: It's an active ecosystem.
• 17:37
  Speaker 2: It really is.
• 17:38
  Speaker 1: So just to recap the massive journey we've taken today,
• 17:41
  Speaker 1: the UAE has fundamentally rewritten the rules. They're executing this
• 17:44
  Speaker 1: huge centralization effort under the twenty twenty four decree, moving
• 17:48
  Speaker 1: away from the fragmented MAILIP system to the unified, highly
• 17:51
  Speaker 1: digital EDE. And to get your medical device into this
• 17:54
  Speaker 1: booming market, you have to navigate a hyper strict pre
• 17:58
  Speaker 1: market dot C process through their ECTV system. You have
• 18:02
  Speaker 1: to bring your FDA or ce mark proofs, but you
• 18:06
  Speaker 1: also have to prove you fit their specific local risk
• 18:09
  Speaker 1: classifications and environmental realities.
• 18:11
  Speaker 2: And you must perfect your bilingual English and Arabic labeling
• 18:15
  Speaker 2: accounting for the complex physical realities of right to left formatting.
• 18:19
  Speaker 1: Yes, the formatting.
• 18:20
  Speaker 2: Plus you are legally required to have a dedicated, deeply
• 18:23
  Speaker 2: operational local partner on the ground to handle accountability and audits.
• 18:27
  Speaker 1: And once you finally cross that finish line and get
• 18:30
  Speaker 1: that golden ticket, that five year ed authorization, you still
• 18:33
  Speaker 1: aren't done.
• 18:34
  Speaker 2: Nope, that's just the start.
• 18:35
  Speaker 1: You are locked into a rigorous, continuous cycle of postmarket vigilance,
• 18:40
  Speaker 1: actively tracking safety data and reporting back to the federal authority.
• 18:44
  Speaker 1: I mean, it is a demanding transition, without a doubt
• 18:46
  Speaker 1: it is. But as the briefing outlines, for those who
• 18:49
  Speaker 1: truly understand the underlying philosophy and align their strategies, it
• 18:52
  Speaker 1: offers a streamline, transparent pathway into one of the most
• 18:56
  Speaker 1: dynamic healthcare markets in the world.
• 18:58
  Speaker 2: It forces manufacturers to bet. It demands excellence from end
• 19:02
  Speaker 2: to end.
• 19:02
  Speaker 1: It really does. And looking at this incredibly advanced digitized
• 19:06
  Speaker 1: system leaves me with one final thought something for you
• 19:09
  Speaker 1: to mol over after we wrap up today. Oh, I
• 19:11
  Speaker 1: love these We've seen how the UAE's EDE is moving
• 19:14
  Speaker 1: entirely to this unified digital tracking grid for both pre
• 19:18
  Speaker 1: market approval and post market safety. They've built an infrastructure
• 19:22
  Speaker 1: that can process data instantly. So if a rapidly growing
• 19:26
  Speaker 1: centralized market like this is utilizing real time digital architecture,
• 19:30
  Speaker 1: how long until global medical device regulation becomes a fully
• 19:34
  Speaker 1: interconnected worldwide network.
• 19:36
  Speaker 2: Wow? That is the ultimate question of modern regulation.
• 19:40
  Speaker 1: Right, I mean, will we soon see a world where
• 19:42
  Speaker 1: an adversaty report logged by a QPPV in a clinic
• 19:45
  Speaker 1: in Dubai instantly and automatically triggers a pause on a
• 19:49
  Speaker 1: product's authorization in a hospital in New York or London.
• 19:52
  Speaker 2: The digital technology to do that already exists exactly.
• 19:55
  Speaker 1: The real question is whether sovereign global regulators will eventually
• 19:59
  Speaker 1: choose to. I think there are digital grids together to create
• 20:02
  Speaker 1: a single worldwide safety net. It's fascinating to think about.
• 20:05
  Speaker 2: It is, and considering the pace of digital modernization we're
• 20:09
  Speaker 2: seeing with authorities like the EDE, a fully integrated global
• 20:13
  Speaker 2: network might be much closer to reality than we think.
• 20:16
  Speaker 1: It is definitely something to keep an eye on. Well,
• 20:18
  Speaker 1: thank you so much for joining us on this deep
• 20:20
  Speaker 1: dive into the UA's new regulatory landscape. We appreciate you
• 20:24
  Speaker 1: taking the time to explore the hidden mechanics of global
• 20:26
  Speaker 1: healthcare with us. Until next time, stay curious.